Testosterone Cypionate 200mg Injection Site Pain

What the Depo-Testosterone label says

'Inflammation and pain at the site of intramuscular injection' is the last entry in the Depo-Testosterone adverse reactions section, filed under miscellaneous reactions [1]. That section is introduced as reactions that 'have occurred with some androgens' and gives no incidence figures [1].

The label is precise about route. Depo-Testosterone is for intramuscular use only, is not to be given intravenously, and is injected deep in the gluteal muscle [1]. Dosing runs 50 to 400 mg every two to four weeks, adjusted to the individual's response and adverse reactions, so 200 mg falls within the labeled range [1]. The label also says parenteral products should be inspected visually for particulate matter and discoloration before administration [1].

What a rate looks like for a 200 mg cypionate dose

Azmiro is a different testosterone cypionate product (listed as discontinued in Drugs@FDA when checked). Its label reports a single-dose study of 200 mg intramuscular in 27 hypogonadal men over 31 days: injection site erythema in 26% and injection site reaction in 4%, all mild [10]. This is one single-dose study of another product, so it is not a rate for Depo-Testosterone.

What to note after an injection

The useful details are direction of change, spread, function, fever, drainage, rash and breathing symptoms:

• Is the pain improving, unchanged or worse than the day before?
• Is redness or swelling staying put or spreading?
• Has fever, drainage, itching, rash or feeling unwell appeared?
• Which product and strength (100 or 200 mg/mL), what volume, which site, who gave it, and how soon the soreness started?

Keeping the same record after each injection shows whether the pattern repeats.

What MedlinePlus lists as urgent

MedlinePlus's intramuscular injection guidance lists a rash, intense itching, trouble breathing, or swelling of the mouth, lips or face after an injection as reasons to call 911 or the local emergency number right away [5]. The same guidance lists fever or feeling ill after an injection, and a lump, bruise or swelling at the injection site that does not go away, as warning signs [5].

The Depo-Testosterone label lists hypersensitivity, including skin manifestations and anaphylactoid reactions, among adverse reactions, and known hypersensitivity to the drug is one of its contraindications [1].

The label's venous thromboembolism warning concerns pain, edema, warmth and erythema in a lower extremity, which means a leg rather than the gluteal injection site [1].

Injection technique and safety

CDC guidance calls for a sterile, single-use, disposable needle and syringe for each injection and aseptic technique in preparing and giving it [6]. These are infection-prevention measures.

MedlinePlus's general intramuscular instructions describe the practical steps: a new needle and syringe long enough to get deep into the muscle, cleaning the skin with an alcohol wipe and letting it dry, a quick firm thrust at a 90-degree angle, and a different spot for each additional injection [5]. For subcutaneous testosterone, MedlinePlus says not to inject into skin that is tender, bruised, red or hard [7].

Does subcutaneous injection hurt less?

The relevant studies were done in transgender adults on gender-affirming therapy, not in men with hypogonadism, and they used cypionate or enanthate.

In a prospective, open-label crossover pilot, 14 transgender males with a mean age of 30 who were already on stable intramuscular testosterone cypionate or enanthate self-injected intramuscularly for 3 weeks and then subcutaneously for 8 weeks [3]. Total testosterone exposure was comparable between routes, and weekly questionnaires showed lower self-reported scores on the subcutaneous route for pre-injection anxiety, pain during injection and post-injection pain [3]. The pilot was small and open-label [3].

In a retrospective series of 63 transgender patients using weekly subcutaneous cypionate or enanthate at 50 to 150 mg, 9 reported minor and transient local reactions [4]. Of the 22 who had previously used intramuscular injections, all 22 preferred the subcutaneous route (20 markedly and 2 mildly), and none preferred intramuscular [4].

Depo-Testosterone itself is labeled for deep gluteal intramuscular use only [1].

Ingredients in the vial

The 200 mg/mL Depo-Testosterone solution contains, per mL, testosterone cypionate 200 mg, benzyl benzoate 0.2 mL, cottonseed oil 560 mg and benzyl alcohol 9.45 mg as preservative [2]. The 100 mg/mL strength contains 0.1 mL benzyl benzoate and 736 mg cottonseed oil per mL [2]. Per mL, the stronger vial therefore carries twice the benzyl benzoate and less cottonseed oil.

Depo-Testosterone lists hypersensitivity among its adverse reactions, and a 2024 case report in Contact Dermatitis was titled as a delayed hypersensitivity reaction to testosterone cypionate injections [1][8]. A single case report describes one event and gives no rate.